CLU and Alzheimer disease: The strongest findings of this study included an association of clusterin with cognitive decline, replicating the findings of Thambisetty et al. (128), along with an association of fetuin B and pancreatic polypeptide with brain atrophy, and an association of pancreatic polypeptide and PSA-ACT with a diagnosis of AD (134).